Stifel Nicolaus is out with its report today on National Health Investors NHI, maintaining Hold.
In its report, Stifel Nicolaus writes, "While there is a lot we like about NHI, it has sold off roughly in proportion to other healthcare REITs so we are keeping our rating at Hold but continue to recommend for income investors on Stifel Nicolaus' REIT Income List."
At the time of posting, shares of NHI were trading at $40.06, down 1.33% from Friday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in